Co-Authorship. If the article was prepared jointly with other authors, the signatory of this form warrants that he/she has been authorized by all co-authors to sign this agreement on their behalf, and agrees to inform his/her co-authors of the terms of this agreement.
Co-Authorship. If the article was prepared jointly with other authors, the signatory of this form warrants that s/he has been authorized by all co-authors to sign this agreement on their behalf, and agrees to inform his/her co-authors of the terms of this agreement. Corresponding Author's Signature: ............................................................................................. Name printed: ...............................................................................................................................
Co-Authorship. There is no limit to the number of times an individual may appear as co-author on abstracts. The first author must inform and have agreement from all co-authors of the abstract submission. The first author will be required to confirm this information when submitting the abstract. The first author is also responsible for notifying all authors of any and all correspondence relating to this abstract submission.
Co-Authorship. Subject to the consent of Principal Investigator, should the Company Results be usable, Principal Investigator will be listed as a co-author on any Publications using the Company Results. This provision as written is somewhat strained since the PI may not actually be contributing. Consider adding language giving the PI the option to review and substantively contribute or even state in the language that the PI will be listed on any publication as a “substantial contributor.” COMMENTS
Co-Authorship. If the article was prepared jointly with other authors, the signatory of this form warrants that he/she has been authorized by all co-authors to sign this agreement on their behalf, and agrees to inform his/her co-authors of the terms of this agreement. Corresponding Author’s Signature:…………………………………………………………………. Name printed: ………………………………………………………………………………………. Date: ………………………………………………………………………………………………… ACTA CHEMICA IASI “Alexandru Xxxx Xxxx” University of Xxxx, Xxxxx X, 11, 700506-Iaşi ROMANIA, Fax: 0000-000-000000
Co-Authorship. If the article was prepared jointly with other authors, the signatory of this form warrants that he/she has been authorized by all co-authors to sign this agreement on their behalf, and agrees to inform his/her co-authors of the terms of this agreement. 2 6. Termination This agreement can be terminated by the author or the Journal Owner upon two months’ notice where the other party has materially breached this agreement and failed to remedy such breach within a month of being given the terminating party’s notice requesting such breach to be remedied. No breach or violation of this agreement will cause this agreement or any license granted in it to terminate automatically or affect the definition of the Journal Owner. After the lapse of forty (40) years of the date of this agreement, this agreement can be terminated without cause by the author or the Journal Owner upon two years’ notice. The author and the Journal Owner may agree to terminate this agreement at any time. This agreement or any license granted in it cannot be terminated otherwise than in accordance with this section 6.
Co-Authorship. If the article was prepared jointly with other authors, the signatory of this form warrants that he has been authorized by all co-authors to sign this agreement on their behalf, and agrees to inform his co- authors of the terms of this agreement. Corresponding Author’s Signature: ………………………………………… Name Printed: ……………………………………………………………… Date: ……………………………………………………………………….. Radiology and Oncology (ISSN 1318-2099) is a multidisciplinary journal devoted to-the publishing of original and high quality articles in diagnostic and interventional radiology, computerized tomography, ultrasound, magnetic resonance, nuclear medicine, radiotherapy, clinical and experimental oncology, radiobiology, radiophysics, and radiation protection. Therefore, the scope of the journal is to cover beside radiology diagnostic and therapeutic aspects in oncology, which distinguishes it from other journals in the field.
Co-Authorship. Dissertation chairs and committee members who collaborate with the participant (graduate doctoral student) in developing the and publishing the manuscript become co- author. The participant would be the first author. The order of co-authorship for the remaining of the authors corresponds with the amount contributions to the manuscript development. • Reviewers will not be coauthor if they provide feedback and support for manuscript development. However, if the reviewers in addition to providing feedback start editing and revising the manuscripts they may become eligible for coauthor-ship. A written consent for coauthor-ship completed by both participant and reviewer must be provided to the workshop leadership prior entering to coauthor-ship.
Co-Authorship. All Data Partners participating in the study are permitted to include the co-investigator and other study contributors as co-authors in presentations, reports, abstracts or publications, assuming co-authors meet authorship criteria. The Data User is responsible for soliciting co-authorship information from Data Partners. If no co-authors are provided by a Data Partner, the Data User must secure institutional approval of presentations, reports, abstracts or publications materials from the Data Partner’s CODI institutional lead listed in “Exhibit A”. When approval of presentations, reports, abstracts or publications is needed, Data User will allow at least 5 business days for response. If Data Partner is not responsive within the allotted review time period, the Data User is permitted to proceed without approval.
Co-Authorship. The transfer of copyrights should be signed by all authors. If the article was written in the course of employment by the US or UK Government, and/or arises from NIH funding, please consult Xxxxx Institute of Occupational Medicine for further instructions. Authors’ Signatures: ......................................................................................................................................................................................................................................................................................................................................................................................................................................................................................... Name printed: .......................................................................................................................................................................................................................................................................................….…....................................................................................................................................................................................... Date: ......................................
